Market Cap 1.28B
Revenue (ttm) 87.37M
Net Income (ttm) -301.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -345.36%
Debt to Equity Ratio 0.00
Volume 860,700
Avg Vol 1,897,610
Day's Range N/A - N/A
Shares Out 89.17M
Stochastic %K 17%
Beta -0.33
Analysts Strong Sell
Price Target $18.50

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fix...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 682 0917
Website: amylyx.com
Address:
43 Thorndike Street, Cambridge, United States
ajmore
ajmore Oct. 24 at 7:12 PM
$AMLX the 16.94 on Tuesday is a reminder: close your short(s)! Enjoy weekend.
0 · Reply
I_AM_GHEY
I_AM_GHEY Oct. 24 at 1:57 PM
$AMLX That bounce off $14.08 was huge. If it gives that up it will likely test $13.50. Long hold until $20+
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 24 at 1:21 PM
$NEWH Good Morning ☕️ $RXRX $SANA $AMLX
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 23 at 1:39 PM
$RXRX Good Morning ☕️ $AMLX $SANA $NEWH
0 · Reply
Digger75
Digger75 Oct. 22 at 7:05 PM
0 · Reply
ajmore
ajmore Oct. 21 at 1:54 PM
$AMLX options chain! even 37 is within reach.
1 · Reply
I_AM_GHEY
I_AM_GHEY Oct. 21 at 1:37 PM
$AMLX Still an easy hold
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 21 at 1:27 PM
$AMLX 🚀☕️
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 21 at 12:49 PM
$RXRX Good Morning ☕️ $SANA $AMLX
0 · Reply
Brianum2011
Brianum2011 Oct. 20 at 11:40 PM
$SANA Already have sana, would you take $CELC or $AMLX for a long term investment?
1 · Reply
Latest News on AMLX
Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery

Jul 14, 2025, 2:15 PM EDT - 3 months ago

Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery


Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market

Jun 24, 2025, 2:59 PM EDT - 4 months ago

Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market


ajmore
ajmore Oct. 24 at 7:12 PM
$AMLX the 16.94 on Tuesday is a reminder: close your short(s)! Enjoy weekend.
0 · Reply
I_AM_GHEY
I_AM_GHEY Oct. 24 at 1:57 PM
$AMLX That bounce off $14.08 was huge. If it gives that up it will likely test $13.50. Long hold until $20+
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 24 at 1:21 PM
$NEWH Good Morning ☕️ $RXRX $SANA $AMLX
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 23 at 1:39 PM
$RXRX Good Morning ☕️ $AMLX $SANA $NEWH
0 · Reply
Digger75
Digger75 Oct. 22 at 7:05 PM
0 · Reply
ajmore
ajmore Oct. 21 at 1:54 PM
$AMLX options chain! even 37 is within reach.
1 · Reply
I_AM_GHEY
I_AM_GHEY Oct. 21 at 1:37 PM
$AMLX Still an easy hold
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 21 at 1:27 PM
$AMLX 🚀☕️
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 21 at 12:49 PM
$RXRX Good Morning ☕️ $SANA $AMLX
0 · Reply
Brianum2011
Brianum2011 Oct. 20 at 11:40 PM
$SANA Already have sana, would you take $CELC or $AMLX for a long term investment?
1 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 20 at 8:04 PM
$AMLX Great day guys🍺 $RXRX $SANA
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 20 at 6:27 PM
$RXRX WHEN Not If this $SANA $AMLX hits $120, my life will significantly change🍺 ✈️
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 20 at 2:26 PM
$RXRX Good Morning ☕️ $SANA $AMLX
0 · Reply
Stekli27
Stekli27 Oct. 18 at 10:21 PM
$NRSN People forget that biotech breakouts never happen when everyone expects them. Look at $ATHA, $ANVS, $AMLX, all were completely dead for weeks before exploding 300 to 600 percent. Same setup here: AI based patient stratification, strong Phase 2 data in ALS and Alzheimer’s, and a ready to go Phase 3 program waiting for funding or a deal. No hype, no noise, no attention, exactly how it looked before the big runs in 2022 to 2024. The difference now is that NRSN targets two major diseases and combines it with AI driven biomarker precision. The market doesn’t understand it yet, but when the announcement comes, it won’t wait. Quiet periods like this are not weakness. They are compression before the spring snaps.
2 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 17 at 6:22 PM
$RXRX GEMS RUNS! 💎 🏃‍♂️ s $SANA $AMLX
0 · Reply
SilentBull69
SilentBull69 Oct. 17 at 5:33 PM
$AMLX Time to move back up…..let’s cross 16
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 17 at 4:25 PM
$RXRX Good Morning ☕️ Hello 💎 s $SANA $AMLX
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:21 PM
Citigroup has adjusted their stance on Amylyx Pharmaceuticals ( $AMLX ), setting the rating to Buy with a target price of 12 → 20.
0 · Reply
ajmore
ajmore Oct. 17 at 10:31 AM
$AMLX Citi raises target from 12 to 20.
0 · Reply
ajmore
ajmore Oct. 16 at 5:44 PM
$AMLX when Trump tweets you know 1. Its the poker game, 2. deal almost there hes just doing final touches and 3. if you are short you cover, not day to short, its the day you go long! target 40.
0 · Reply
LoveRetailFroth
LoveRetailFroth Oct. 16 at 1:31 PM
$SANA Good Morning ☕️ $RXRX $AMLX
0 · Reply
TeeMan123
TeeMan123 Oct. 16 at 12:32 PM
$AMLX look at prax and qure as guidepost… if AMLX can show a signal in the ALS readout before year end, the stock is going to fly
0 · Reply